Safety and tolerability of Meningococcus B vaccine in patients with chronical medical conditions (CMC)

Safety and tolerability of Meningococcus B vaccine in patients with chronical medical conditions (CMC)

Abstract Background Invasive meningococcal disease is a serious global health threat in the world; in 2016, the European Centre for Disease Control and Prevention reported 3280 confirmed cases (including 304 deaths) of Invasive Meningococcal Diseases in Europe. In Italy, in 2017 were reported 200 ca...

Full description

Bibliographic Details
Main Authors: L. Nicolosi, C. Rizzo, G. Castelli Gattinara, N. Mirante, E. Bellelli, C. Bianchini, V. Pansini, A. Villani
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Italian Journal of Pediatrics
Subjects:
Invasive meningococcal disease
Vaccination
Vaccine adverse events
Group B meningococcus
Online Access:http://link.springer.com/article/10.1186/s13052-019-0730-y

Internet

http://link.springer.com/article/10.1186/s13052-019-0730-y

Similar Items